Radical Hysterectomy and Pelvic Lymphadenectomy Versus Radiation Therapy for Small (≤3 cm) Stage IB Cervical Carcinoma

Authors:
  • DMDavid L. Marchetti
    David L. Marchetti
  • TPThomas Patton
    Thomas Patton
  • JHJoshua Halpern
    Joshua Halpern
  • LBLeslie Blumenson
    Leslie Blumenson
  • DDDeborah L. Driscoll
    Deborah L. Driscoll

Abstract
One hundred and three women with FICO stage IB cervical carcinoma were treated either by radical hysterectomy and bilateral pelvic lymphadenectomy, or external pelvic radiation and intracavitary brachytherapy to deliver .gtoreq. 6000 rads to point A. Surgical therapy was to be limited to stage IB tumors measuring .ltoreq. 3 cm in greatest diameter, Patients with lesions > 3 cm, medical contraindications to surgery, or advanced age were to be treated by radiation therapy. Of the 55 women treated surgically, 3 (5.6%) were found on final histologic evaluation to have tumors > 3 cm. The 5-year estimated disease-free interval was 92.3% for patients treated by surgery and 91.1% for patients treated by radiation therapy. Similar rates were achieved for the 5-year disease-free interval for lesions > 1 cm, 1-3 cm, and > 3 cm in diameter by either surgery or radiation. It is tentatively concluded that radical hysterectomy and pelvic lymphadenectomy or radiation therapy as outlined above provide equally good disease-free intervals for stage IB cervical tumors measuring .gtoreq. 3 cm in diameter. Because of a bias against patients treated with radiation, it is possible that radiation could lead to better results than surgery in comparable (younger, healthier, thinner) population. The advantage of surgical treatment in the younger patient is preservation of ovarian function.